Literature DB >> 23589362

Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients.

Yunbin Ye1, Aimin Huang, Chuanzhong Huang, Jingfeng Liu, Bin Wang, Kecan Lin, Qiang Chen, Yongyi Zeng, Huijing Chen, Xuan Tao, Guangya Wei, Yanbin Wu.   

Abstract

PURPOSE: To define mitochondrial protein markers related to liver cancer. EXPERIMENTAL
DESIGN: Mitochondrial subproteomes of 20 patient-derived liver carcinoma and tumor-free control tissues were performed by 2DE coupled with MALDI-TOF/TOF. The altered patterns of three identified proteins were validated by Western blot and immunohistochemistry.
RESULTS: The results showed that compared with tumor-free control samples, nine proteins were downregulated and six proteins were upregulated in carcinoma samples. The increased expression of Arg1 mRNA and protein was validated by Western blot, Q-RT-PCR, paraffin tissue microarray and immunohistochemistry. Furthermore, a literature review shows that Heat shock protein 10 (Hsp10), single-stranded DNA-binding protein (SSBP1), and peptidyl-prolyl cis-trans isomerase A (PPIA), which were identified as being increased in the tumor samples in this study, may be closely related to protein folding and translation. CONCLUSIONS AND CLINICAL RELEVANCE: These results show that in addition to changes in the signaling pathways, such as the Ras-Raf-MEK-ERK pathway, altered mitochondrial DNA replication and protein folding in liver cancer are also worth studying further. Collectively, these results suggest that specific mitochondrial proteins are uniquely susceptible to alterations in expression and carry implications for the investigation of their potential as therapeutic and prognostic markers. Further studies focusing on these proteins will be used to predict treatment response and reverse the apoptosis resistance.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589362     DOI: 10.1002/prca.201100103

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  12 in total

1.  Simple, reliable, and time-efficient colorimetric method for the assessment of mitochondrial function and toxicity.

Authors:  Faraz Ahmad; Widyan Alamoudi; Shafiul Haque; Mohammad Salahuddin; Khaldoon Alsamman
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

2.  UPregulated single-stranded DNA-binding protein 1 induces cell chemoresistance to cisplatin in lung cancer cell lines.

Authors:  Xiang Zhao; Rong He; Yu Liu; Yongkai Wu; Leitao Kang
Journal:  Mol Cell Biochem       Date:  2017-02-16       Impact factor: 3.396

3.  An innovative strategy to clone positive modifier genes of defects caused by mtDNA mutations: MRPS18C as suppressor gene of m.3946G>A mutation in MT-ND1 gene.

Authors:  María Elena Rodríguez-García; Francisco Javier Cotrina-Vinagre; Patricia Carnicero-Rodríguez; Francisco Martínez-Azorín
Journal:  Hum Genet       Date:  2017-05-19       Impact factor: 4.132

4.  Expression profiling of mitochondria-associated microRNAs during osteogenic differentiation of human MSCs.

Authors:  Hongjun Zheng; Jin Liu; Jinsheng Yu; Audrey McAlinden
Journal:  Bone       Date:  2021-06-15       Impact factor: 4.398

5.  Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.

Authors:  Zhenkun Liu; Song Xu; Lu Li; Xiaorong Zhong; Chun Chen; Yaguang Fan; Wang Shen; Lingling Zu; Feng Xue; Min Wang; Qinghua Zhou
Journal:  Thorac Cancer       Date:  2019-04-04       Impact factor: 3.500

6.  High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma.

Authors:  Shilong Wang; Minghuan Li; Ligang Xing; Jinming Yu
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

7.  SSBP1 Upregulation In Colorectal Cancer Regulates Mitochondrial Mass.

Authors:  Yongping Yang; Chenxi Pan; Lingyun Yu; Hongxia Ruan; Ling Chang; Jingbo Yang; Zihan Zheng; Feng Zheng; Tongjun Liu
Journal:  Cancer Manag Res       Date:  2019-12-02       Impact factor: 3.989

Review 8.  Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma.

Authors:  Argyrios Periferakis; Georgios Tsigas; Aristodemos-Theodoros Periferakis; Ioana Anca Badarau; Andreea-Elena Scheau; Mircea Tampa; Simona Roxana Georgescu; Andreea Cristiana Didilescu; Cristian Scheau; Constantin Caruntu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-27       Impact factor: 2.916

9.  Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.

Authors:  Weibing Fan; Shuang-Shi Fan; Juan Feng; Desheng Xiao; Songqing Fan; Jiadi Luo
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

10.  Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients.

Authors:  Yaoxiang Tang; Yang Yang; Jiadi Luo; Sile Liu; Yuting Zhan; Hongjing Zang; Hongmei Zheng; Yuting Zhang; Juan Feng; Songqing Fan; Qiuyuan Wen
Journal:  Cancer Biomark       Date:  2021       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.